SCHEMBL4284433

SCHEMBL4284433

COC(=O)C(C)(C)C(O)c1ccc(O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.44
▸ ESR2 Q92731 2/20 0.44
▸ ELANE P08246 3/20 0.43
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA7 P43166 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ CA14 Q9ULX7 2/20 0.42
▸ CYP26A1 O43174 7/20 0.40
▸ CYP2C9 P11712 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ THPO P40225 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NMUR2 Q9GZQ4 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598842 0.85 ESR1 (0.45) ESR1ESR2ELANECA12CA1
SCHEMBL4278598 0.84 ADRB2 (0.40) ELANECYP26A1CYP2C9ADRB2ADRB1
SCHEMBL10905859 0.83 KCNN4 (0.50) CYP26A1CYP2C9ALDH1A1CYP1A2CYP3A4
SCHEMBL4285619 0.78 ALDH1A1 (0.62) CYP26A1ALDH1A1SMN1; SMN2KDM4EADRB2
SCHEMBL13448250 0.76 CYP26A1 (0.37) CYP26A1
SCHEMBL13304117 0.75 BLM (0.39) CYP26A1BLMNPSR1
SCHEMBL11481283 0.74 SMN1; SMN2 (0.56) ALDH1A1BLMSMN1; SMN2KDM4EHIF1A
SCHEMBL2452815 0.73 ESR1 (0.50) ESR1ESR2CA12CA1CA2
SCHEMBL4280477 0.73 GABBR2 (0.49) CYP26A1CYP2C9SMN1; SMN2NPSR1CYP1A2
SCHEMBL384968 0.72 ESR1 (0.58) ESR1ESR2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009153566-A1 CYP26 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2009-12-23 — — WO disclosed
WO-2009153566-A1 CYP26 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2009-12-23 — — WO disclosed
Send feedback